Ocular Therapeutix CMO Sells Shares to Cover RSU Taxes as Trial Data and Analyst Views Reverberate
Nadia Waheed, Chief Medical Officer at Ocular Therapeutix, sold 3,510 shares on February 20, 2026, to satisfy tax withholding tied to recently vested restricted stock units. The sale, disclosed in a Form 4 filing, followed a pre-arranged automatic instruction adopted in June 2024. The stock has been volatile amid positive Phase 3 SOL-1 data for AXP…